Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma - Drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: A case report study

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 6, 1999, Pages 516-519

  Nannan Panday, Vinodh R ^a,b   Hoetelmans, Richard M W ^b   Van Heeswijk, Rolf P G ^b   Meenhorst, Pieter L ^b   Inghels, Marijke ^b   Mulder, Jan Willem ^b   Beijnen, Jos H ^a,b,c  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antiretroviral agents; Kaposi's sarcoma; Paclitaxel; Pharmacokinetics

Indexed keywords

INDINAVIR; NEVIRAPINE; PACLITAXEL; RITONAVIR; SAQUINAVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MALE; PARESTHESIA; PRIORITY JOURNAL; RASH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG INTERACTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; REVERSE TRANSCRIPTASE INHIBITORS; SARCOMA, KAPOSI;

EID: 0032943910     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050932     Document Type: Article

References (28)

1. Beiser C (1997) HIV infection.II. Clinical review. BMJ 314: 579
2. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2: 1843
3. Cohn JA (1997) HIV infection. I. Clinical review. BMJ 314: 487
4. Committee for Proprietary Medicinal Products (CPMP) (1996) European Public Assessment Report (EPAR), Norvir. CPMP/527/96. Aug 16, CPMP, London, UK
5. Coukell AJ, Spencer CM (1997) Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of the AIDS-related Kaposi's sarcoma. Drugs 53: 520
6. Cresteil T, Monsarrat B, Alvinerie P, Tréluyer JM, Vieira I, Wright M (1994) Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 54: 386
7. Duchin K, Sun J, Tan M, Ilaw M, Cabriales S, Espina BM, East D, Tulpule A, Gill PS (1997) Pharmacokinetics of low-dose Paxene (paclitaxel) in patients with refractory or relapsed AIDS-related Kaposi's sarcoma. Proc Am Soc Clin Oncol 16: 235A
8. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM (1995) Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13: 996
9. Gill PS, Tulpule A, Reynolds T, Hadjenberg J, Mocharnuk R, Espina BM, Bresnahan J, Cabriales S, Ilaw M, Shea K, Scadden DT (1996) Paclitaxel (Taxol) in the treatment of relapsed or refractory advanced AIDS-related Kaposi's sarcoma. Proc Am Soc Clin Oncol 15: 306
10. Harris JW, Rahman A, Kim B-R, Guengerich FP, Collins JM (1994) Metabolism of Taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 54: 4026
11. Hoetelmans RMW, Essenberg M van, Meenhorst PL, Mulder JW, Beijnen JH (1997) Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chromatogr [B] 698: 235
12. Hoetelmans RMW, Meenhorst PL, Mulder JW, Burger DM, Koks CHW, Beijnen JH (1997) Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir. Pharm World Sci 19: 159
13. Hoetelmans RMW, Essenberg M van, Profijt M, Meenhorst PL, Mulder JW, Beijnen JH (1998) High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva. J Chromatogr [B] 705: 119
14. Huizing MT, Keung ACF, Rosing H, Kuij V van der, Bokkel Huinink WW ten, Mandjes I, Dubbelman AC, Pinedo HM, Beijnen JH (1993) Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin Oncol 11: 2127
15. Huizing MT, Giaccone G, Van Warmerdam LJC, Rosing H, Bakker PJM, Vermorken JB, Postmus PE, Van Zandwijk N, Koolen MGJ, Bokkel Huinink WW ten, Van der Vijgh WJF, Bierhorst FJ, Lai A, Dalesio O, Pinedo HM, Veenhof CHN, Beijnen JH (1997) Pharmacokinetics of paclitaxel and carboplatin in a dose escalating study in patients with NSCLC: an ECC trial. J Clin Oncol 15: 317
16. Kim RB, Fromm MF, Wandel C, Leake B, Wood AJJ, Roden DM, Wilkinson GR (1998) The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest 101: 289
17. Krown SE, Metroka C, Wernz JC, AIDS Clinical Trials Group Oncology Committee (1989) Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7: 1201
18. Lee F-C, Mitsuyasu RT (1996) Chemotherapy of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am 10: 1051
19. Merry C, Barry MG, Mulcahy F, Ryan M, Heavey J, Tjia JF, Gibbons SE, Breckenridge AM, Back DJ (1997) Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS 11: F29
20. Miles SA (1996) Pathogenesis of AIDS-related Kaposi's sarcoma. HematolOncol Clin North Am 10: 1011
21. Murphy RL, Montaner J (1996) Nevirapine: a review of its development, pharmacological profile and potential for clinical use. Exp Opin Invest Drugs 5: 1183
22. Nannan Panday VR, Huizing MT, Willemse PHB, De Graeff A, Bokkel Huinink WW ten, Vermorken JB, Beijnen JH (1997) Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function. Semin Oncol 24 [Suppl 11]: S34
23. Saville MW, Lietzau J, Pluda JM, Feuerstein A, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S, Yarchoan R (1995) Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346: 26
24. Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ (1998) Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 16: 683
25. Thompson EW, Nakamura S, Shima TB, Melchiori A, Martin GR, Zaki Salahuddin S, Gallo RC, Albini A (1991) Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res 51: 2670
26. Van Heeswijk RPG, Hoetelmans RMW, Meenhorst PL, Mulder JW, Beijnen JH (1998) Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr [B] (in press)
27. Van Heeswijk RPG, Hoetelmans RMW, Harms R, Meenhorst PL, Mulder JW, Lange JMA, Beijnen JH (1998) Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr [B] (in press)
28. Welles L, Saville MW, Lietzau J, Pluda JM, Wyvill KM, Feuerstein I, Figg WD, Lush R, Odom J, Wilson WH, Fajardo MT, Humphrey RW, Feigal E, Tuck D, Steinberg SM, Broder S, Yarchoan R (1998) Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 16: 1112